| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Carter Todd Alfred is a Chief Scientific Officer at Voyager Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $605K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,174 | $3.76 | $15,694.24 | -2.8% | - | - | |
| Feb 10, 2026 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,525 | $3.85 | $13,571.25 | -2.2% | +9.5% | - | |
| Feb 20, 2025 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,305 | $4.26 | $14,079.30 | -4.1% | -26.1% | -18.1% | |
| Feb 11, 2025 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,413 | $4.45 | $24,087.85 | -6.3% | -20.3% | -13.2% | |
| Jan 14, 2025 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,191 | $5.13 | $6,109.83 | -1.4% | -36.8% | -18.2% | |
| Feb 21, 2024 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,967 | $7.50 | $29,759.91 | -2.2% | +10.5% | -44.2% | |
| Jan 17, 2024 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,266 | $7.18 | $9,089.88 | -2.3% | +9.3% | -30.7% | |
| Sep 15, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 10,500 | $8.16 | $85,680.00 | -16.2% | -2.0% | -21.5% | |
| Jul 6, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,500 | $10.80 | $59,400.00 | -8.4% | -34.3% | -29.3% | |
| Jun 30, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,000 | $11.41 | $57,050.00 | -7.1% | -32.6% | -30.9% |